Ashland Inc. (ASH)

Revenue by Geography

Financials in millions USD. Fiscal year is October - September.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014
Period Ending	Dec 31, 2025	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020	Sep 30, 2019	Sep 30, 2018	Sep 30, 2017	Sep 30, 2016	Sep 30, 2015	Sep 30, 2014
United States Revenue	-	464.00M	624.00M
United States Revenue Growth	-	-25.64%	-1.58%
International Revenue	-	1.36B	1.49B
International Revenue Growth	-	-8.66%	-4.37%
Revenue (Total)	1.81B	1.82B	2.11B
Revenue (Total) Growth	-1.04%	-13.68%	-3.56%

Revenue

Financials in millions USD. Fiscal year is October - September.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014
Period Ending	Dec 31, 2025	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020	Sep 30, 2019	Sep 30, 2018	Sep 30, 2017	Sep 30, 2016	Sep 30, 2015	Sep 30, 2014
Life Sciences Revenue	646.00M	641.00M	810.00M
Life Sciences Revenue Growth	0.78%	-20.86%	-6.79%
Personal Care Revenue	567.00M	577.00M	634.00M
Personal Care Revenue Growth	-1.73%	-8.99%	6.02%
Specialty Additives Revenue	498.00M	511.00M	572.00M
Specialty Additives Revenue Growth	-2.54%	-10.66%	-4.67%
Intermediates Revenue	134.00M	137.00M	144.00M
Intermediates Revenue Growth	-2.19%	-4.86%	-22.16%
Eliminations from Revenue	-39.00M	-42.00M	-47.00M
Revenue (Other)	-1.00M	-	-
Revenue (Total)	1.81B	1.82B	2.11B
Revenue (Total) Growth	-1.04%	-13.68%	-3.56%

EBIT

Financials in millions USD. Fiscal year is October - September.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014
Period Ending	Dec 31, 2025	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020	Sep 30, 2019	Sep 30, 2018	Sep 30, 2017	Sep 30, 2016	Sep 30, 2015	Sep 30, 2014
Life Sciences Operating Income	-259.00M	-262.00M	168.00M
Life Sciences Operating Income Growth	-	-	-2.33%
Personal Care Operating Income	90.00M	90.00M	73.00M
Personal Care Operating Income Growth	-	23.29%	40.38%
Specialty Additives Operating Income	-341.00M	-338.00M	-32.00M
Intermediates Operating Income	-	8.00M	29.00M
Intermediates Operating Income Growth	-	-72.41%	-42.00%
Unallocated and Other Operating Income	-97.00M	-273.00M	-264.00M
Operating Income (Other)	5.00M	-	-
Operating Income (Total)	-602.00M	-775.00M	-26.00M

EBITDA

Financials in millions USD. Fiscal year is October - September.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014
Period Ending	Dec 31, 2025	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020	Sep 30, 2019	Sep 30, 2018	Sep 30, 2017	Sep 30, 2016	Sep 30, 2015	Sep 30, 2014
Life Sciences EBITDA	-183.00M	-187.00M	229.00M
Life Sciences EBITDA Growth	-	-	-4.98%
Personal Care EBITDA	151.00M	155.00M	152.00M
Personal Care EBITDA Growth	-2.58%	1.97%	10.95%
Specialty Additives EBITDA	-254.00M	-254.00M	89.00M
Specialty Additives EBITDA Growth	-	-	3.49%
Intermediates EBITDA	15.00M	21.00M	42.00M
Intermediates EBITDA Growth	-28.57%	-50.00%	-33.33%
Unallocated and Other EBITDA	-97.00M	-273.00M	-264.00M
Operating Income (Other)	-234.00M	-237.00M	-274.00M
Operating Income (Total)	-602.00M	-775.00M	-26.00M

Key Performance Indicators

Financials in millions USD. Fiscal year is October - September.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014
Period Ending	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020	Sep 30, 2019	Sep 30, 2018	Sep 30, 2017	Sep 30, 2016	Sep 30, 2015	Sep 30, 2014
Change in Sales Due to Volume	-98.00M	1.00M
Change in Sales Due to Product Pricing/Mix	-46.00M	-78.00M

Updated Dec 31, 2025. Data Source: Fiscal.ai.